The increasing number of prostate cancer cases and rising strategic initiatives by the prostate cancer therapeutics market players bolster the prostate cancer therapeutics market size. However, the high cost associated with prostate cancer therapeutics hinders the growth of prostate cancer therapeutics market growth. Growing Demand for Targeted Therapy to Become Trend in Prostate Cancer Therapeutics […]
Sarcopenia Treatment Market was valued at US$ 3,397.62 Million in 2022 and is expected to reach to US$ 5,264.76 Million by 2030; it is estimated to record a CAGR of 5.6% from 2022 to 2030
Rising Awareness of Sarcopenia to Bring New Growth Trends into Sarcopenia Treatment Market The growing awareness of sarcopenia and its negative impact on health presents a significant scope for advancements in the fields of healthcare and geriatric care. Many advocacy groups and organizations are proactively taking steps to raise the awareness of sarcopenia among the […]
Malaria Diagnostics Market was valued at US$ 782.57 Million in 2022 and is expected to reach to US$ 1,200.24 Million by 2030; it is estimated to record a CAGR of 5.5% from 2022 to 2030
Rising Initiatives to Raise Awareness about Malaria Drives Malaria Diagnostics Market According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of […]
Parenteral Nutrition Market was valued at US$ 6.84 Billion in 2022 and is expected to reach to US$ 11.12 Billion by 2030; it is estimated to record a CAGR of 6.2% from 2022 to 2030
Surge in Cases of Malnutrition and Premature Births Drives Parenteral Nutrition Market Malnutrition includes being undernourished, overweight or obese, having inadequate vitamins or minerals, and having a non-communicable disease due to a bad diet. As per World Health Organization (WHO) data, ~1.9 billion adults were overweight or obese, whereas 462 million were underweight in 2021. […]
Oncology Biosimilars Market was valued at US$ 9.46 Billion in 2023 and is expected to reach to US$ 24.71 Billion by 2031; it is estimated to record a CAGR of 12.8% from 2023 to 2031
North America accounts for a major oncology biosimilars market share in 2023, followed by Europe. The growing cases of cancer, rising approvals of biosimilars for cancer treatment, and the advanced healthcare infrastructure are the factors anticipated to propel the oncology biosimilars market in North America. Biologics are the most expensive medicines in the US. Biosimilars […]
Glaucoma therapeutics Market was valued at US$ 6.24 Billion in 2023 and is expected to reach to US$ 8.02 Billion by 2031; it is estimated to record a CAGR of 3.2% from 2023 to 2031
Glaucoma is a group of eye disorders caused due to the damage incurred to the optic nerve, which can eventually lead to total blindness. People with glaucoma may experience a gradual loss of nerve tissue, resulting in vision impairment or blindness if left untreated. Prostaglandin analogs are among the drugs widely recommended for effectively reducing […]
Plasma Therapy Market was valued at US$ 390.25 Million in 2022 and is expected to reach to US$ 1,097.64 Million by 2030; it is estimated to record a CAGR of 13.80% from 2022 to 2030
North America dominated the plasma therapy market in 2022. It is further expected to record the highest CAGR in the market during 2022–2030. The market in North America is segmented into the US, Canada, and Mexico. The US holds the largest market share of the global plasma therapy market. Market growth in the country is […]
Hyperpigmentation Disorder Treatment Market was valued at US$ 6.67 Billion in 2022 and is expected to reach to US$ 11.78 Billion by 2030; it is estimated to record a CAGR of 7.4% from 2022 to 2030
Geographically, the global hyperpigmentation disorder treatment market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. In terms of revenue, Asia Pacific dominated the hyperpigmentation disorder treatment market share in 2022. The hyperpigmentation disorder treatment market in this region is segmented into China, Japan, India, Australia, […]
Hospital Acquired Infection Treatment Market was valued at US$ 15,099.19 Million in 2022 and is expected to reach to US$ 19,978.39 Million by 2030; it is estimated to record a CAGR of 3.6% from 2022 to 2030
Asia Pacific is the fastest-growing market for hospital acquired infection treatment. North America accounted for the largest share of the global hospital acquired infection treatment market in 2022. The US held the largest hospital acquired infection treatment market share in the region in 2022 and is estimated to continue its dominance from 2022 to 2030. […]
Fluorine-18 Market was valued at US$ 1.72 Billion in 2022 and is expected to reach to US$ 2.41 Billion by 2030; it is estimated to record a CAGR of 4.3% from 2022 to 2030
Factors such as the heightened prevalence of chronic diseases and increasing use of nuclear imaging techniques propel the fluorine-18 market growth. However, the short shelf-life of fluorine-18 impedes the growth of the market. Further, the use of radioactive tracers in cancer diagnosis is expected to bring new trends in the market in the coming years. […]